Cargando…
SARS-CoV-2 and allergy – what have we learned after two and a half years?
Background: Coronavirus disease-2019 (COVID-19) has significantly hampered the regular workflow for allergists and allergy departments. Materials and methods: The purpose of this review is to highlight our own experiences on SARS-CoV-2 and allergy as well as to discuss findings from the literature....
Autores principales: | Brockow, Knut, Wang, Rosi, Mathes, Sonja, Bent, Rebekka, Faihs, Valentina, Eberlein, Bernadette, Darsow, Ulf, Biedermann, Tilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088874/ https://www.ncbi.nlm.nih.gov/pubmed/37056446 http://dx.doi.org/10.5414/ALX02373E |
Ejemplares similares
-
Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines
por: Mathes, Sonja, et al.
Publicado: (2022) -
Experience with polyethylene glycol allergy‐guided risk management for COVID‐19 vaccine anaphylaxis
por: Brockow, Knut, et al.
Publicado: (2021) -
Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID‐19 vaccines?
por: Eberlein, Bernadette, et al.
Publicado: (2022) -
PEG allergy — A COVID-19 pandemic-made problem? A German perspective()
por: Bent, Rebekka K., et al.
Publicado: (2022) -
Allergy and sensitization to Hymenoptera venoms in unreferred adults with a high risk of sting exposure
por: Zink, Alexander, et al.
Publicado: (2019)